Molly Harper Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity
Molly Harper is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 6,746 shares of CPRX, which is worth approximately $145,848. The most recent transaction as insider was on Feb 14, 2025, when has been sold 4,000 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
6.75K
Infinity%
3M change
26.5%
12M change
Total Value Held
$145,848
Molly Harper Transaction History
MH
Molly Harper
Director
Coral Gables, FL